Pharmanutra Balance Sheet Health
Financial Health criteria checks 5/6
Pharmanutra has a total shareholder equity of €58.9M and total debt of €23.3M, which brings its debt-to-equity ratio to 39.6%. Its total assets and total liabilities are €115.6M and €56.7M respectively. Pharmanutra's EBIT is €26.4M making its interest coverage ratio 40.7. It has cash and short-term investments of €24.4M.
Key information
39.6%
Debt to equity ratio
€23.32m
Debt
| Interest coverage ratio | 40.7x |
| Cash | €24.40m |
| Equity | €58.90m |
| Total liabilities | €56.70m |
| Total assets | €115.60m |
Recent financial health updates
These 4 Measures Indicate That Pharmanutra (BIT:PHN) Is Using Debt Safely
May 16
Pharmanutra (BIT:PHN) Could Easily Take On More Debt
Jan 11Is Pharmanutra (BIT:PHN) A Risky Investment?
Jan 04Recent updates
Investors Interested In Pharmanutra S.p.A.'s (BIT:PHN) Earnings
Sep 11Pharmanutra's (BIT:PHN) Shareholders Have More To Worry About Than Only Soft Earnings
Mar 23Is Now The Time To Put Pharmanutra (BIT:PHN) On Your Watchlist?
Sep 26These 4 Measures Indicate That Pharmanutra (BIT:PHN) Is Using Debt Safely
May 16Pharmanutra (BIT:PHN) Could Easily Take On More Debt
Jan 11Capital Allocation Trends At Pharmanutra (BIT:PHN) Aren't Ideal
Nov 02Pharmanutra (BIT:PHN) Will Be Hoping To Turn Its Returns On Capital Around
Aug 03Is Now The Time To Put Pharmanutra (BIT:PHN) On Your Watchlist?
May 20Returns On Capital Signal Tricky Times Ahead For Pharmanutra (BIT:PHN)
Apr 19Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmanutra S.p.A.'s BIT:PHN) Stock?
Mar 10Is There More To The Story Than Pharmanutra's (BIT:PHN) Earnings Growth?
Feb 17
Should You Be Adding Pharmanutra (BIT:PHN) To Your Watchlist Today?
Feb 01Is Pharmanutra S.p.A. (BIT:PHN) A Smart Choice For Dividend Investors?
Jan 18Is Pharmanutra (BIT:PHN) A Risky Investment?
Jan 04Shareholders Of Pharmanutra (BIT:PHN) Must Be Happy With Their 220% Total Return
Dec 22Do Insiders Own Lots Of Shares In Pharmanutra S.p.A. (BIT:PHN)?
Dec 08Is Pharmanutra S.p.A.'s(BIT:PHN) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 23Financial Position Analysis
Short Term Liabilities: PHN's short term assets (€63.4M) exceed its short term liabilities (€28.1M).
Long Term Liabilities: PHN's short term assets (€63.4M) exceed its long term liabilities (€28.6M).
Debt to Equity History and Analysis
Debt Level: PHN has more cash than its total debt.
Reducing Debt: PHN's debt to equity ratio has increased from 19.2% to 39.6% over the past 5 years.
Debt Coverage: PHN's debt is well covered by operating cash flow (98.1%).
Interest Coverage: PHN's interest payments on its debt are well covered by EBIT (40.7x coverage).